Updated CR CB
Cobra is now a Charles River Company.

Read the press release in full here.


Cobra has two GMP approved facilities in Sweden and the UK, each with specific expertise tailored to serving our customers around the world. We offer a broad range of integrated and stand-alone contract development and manufacturing services for clinical trials and the commercial market.

As a trusted provider and a key partner in the drug development and commercialisation process, we take pride in our manufacturing excellence and comprehensive range of services to the pharmaceutical and biotech industries.

Our Commitment to You


Cobra is a Contract Development and Manufacturing Organisation (CDMO) supporting the global life sciences industry in the development and manufacture of DNA, viral vectors, microbiota, proteins and pharmaceuticals for clinical trials and commercial supply.


Over 20 years of track record in producing biologics and pharmaceuticals for use in pre-clinical to Phase III clinical trials and commercial supply has given our people a unique knowledge base as both manufacturer and also as service providers for the global life sciences market.

We offer a broad range of integrated and stand-alone development services, bespoke to individual customer requirements, stretching from process development to the supply of investigational medicinal product for clinical trials and commercial market supply.


Every program complies with GMP standards worldwide and is conceived with an unmatched quality derived from the know-how of Cobra’s highly qualified, flexible and dedicated people.

Cobra has two GMP approved facilities; in Sweden our DNA, Microbiota and Fill Finish Facility located in Matfors, and in the United Kingdom our Centre of Excellence for Advanced Therapies (ATMPs), specialising in DNA and viral vector production, located in Keele. Our sites offer a comprehensive service to nurture your project from conception to fill and finish.

Cobra takes pride in manufacturing excellence, delivering what we promise and helping our customers to develop drugs for the benefit of patients.

Our Mission

What we strive to achieve...

To be the trusted service partner to the global life sciences industry for DNA, viral vectors, microbiota and protein process development, production and API fill finish for pre-clinical and through to commercial product supply.

To apply our technical expertise and experience to deliver customer value and take pride in our reputation as a comprehensive service provider.

To enhance our skills and capabilities to meet our customers' needs as their products develop and mature.

Customer: We are focused on delivering excellent customer service

Openness: We will operate openly in partnership with our customers

Best Value: We will generate ideas to continually improve our product and service offerings and provide added value for our customers

Responsiveness: We are pro-active and quick to respond  

Achievement: We have a results delivery orientated attitude